Detalles de la búsqueda
1.
Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study.
Support Care Cancer
; 30(11): 9267-9278, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36066628
2.
Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin.
Support Care Cancer
; 29(8): 4223-4238, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33624117
3.
Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany.
Support Care Cancer
; 28(5): 2175-2184, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31410600
4.
Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany.
Support Care Cancer
; 28(11): 5223-5233, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32086567
5.
Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors.
Support Care Cancer
; 27(7): 2569-2577, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30443809
6.
Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment.
Ann Surg Oncol
; 23(3): 757-66, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467455
7.
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.
Support Care Cancer
; 24(1): 447-455, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26335402
8.
Prognostic value of disseminated tumor cells in the bone marrow of patients with operable primary breast cancer: a long-term follow-up study.
Ann Surg Oncol
; 20(6): 1865-71, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23263703
9.
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities.
Geburtshilfe Frauenheilkd
; 82(2): 181-205, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35197803
10.
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy.
Geburtshilfe Frauenheilkd
; 82(2): 139-180, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35169387
11.
Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.
Support Care Cancer
; 24(1): 457-458, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26482379
12.
Bone pain reduction in patients with metastatic breast cancer treated with ibandronate-results from a post-marketing surveillance study.
Support Care Cancer
; 18(10): 1305-12, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20151162
13.
Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review.
Support Care Cancer
; 17(6): 719-25, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19089462
14.
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019.
Breast Care (Basel)
; 14(4): 247-255, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31558898
15.
A pooled analysis of bone marrow micrometastasis in breast cancer.
N Engl J Med
; 353(8): 793-802, 2005 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-16120859
16.
Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
Crit Rev Oncol Hematol
; 64(3): 198-207, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17855108
17.
Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Am J Obstet Gynecol
; 196(4): 342.e1-9, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17403414
18.
Adverse effects of bisphosphonates: current issues.
J Support Oncol
; 5(10): 475-82, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18240669
19.
Early identification and intervention matters: A comprehensive review of current evidence and recommendations for the monitoring of bone health in patients with cancer.
Cancer Treat Rev
; 61: 23-34, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29100167
20.
Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial.
Clin Drug Investig
; 26(6): 315-22, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17163265